Cite
HARVARD Citation
Hofer, M. (2018). Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology. p. 547. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hofer, M. (2018). Lobaplatin inhibits prostate cancer progression in part by impairing AR and ERG signal. Fundamental & clinical pharmacology. p. 547. [Online].